Sean Bevick
Vice President of Investor Relations
Replay available
Quest Diagnostics Incorporated (DGX) Q4 2025 Earnings Call
Quest Diagnostics Incorporated (NYSE: DGX) Q4 2025 earnings conference call, held 2026-02-10. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Jim Davis
Chairman, Chief Executive Officer and President
Sam Samad
Chief Financial Officer
Luke Sergot
Analyst, Barclays
Patrick Donnelly
Analyst, Citi
Michael Cherney
Analyst, The Ring Partners
Erin Wright
Analyst, Morgan Stanley
Kevin Caliendo
Analyst, UBS
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Quest Diagnostics Incorporated.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.456 Welcome to the Quest Diagnostics fourth quarter and year-end 2025 conference call. 00:00:05.456 -- 00:00:08.939 At the request of the company, this call is being recorded. 00:00:08.939 -- 00:00:12.742 The entire contents of the call, including the presentation and the question and answer 00:00:12.742 -- 00:00:17.126 session that will follow, are the copyrighted property of Quest Diagnostics with all 00:00:17.126 -- 00:00:22.130 rights reserved. Any redistribution, retransmission, or rebroadcast of this call in any 00:00:22.130 -- 00:00:27.075 form without the written consent of Quest Diagnostics is strictly prohibited. 00:00:27.075 -- 00:00:30.682 Now I'd like to introduce Sean Bevick, Vice President of Investor Relations for Quest 00:00:30.682 -- 00:00:34.324 Diagnostics. Please go ahead. 00:00:35.488 -- 00:00:40.815 Thank you and good morning. I'm joined by Jim Davis, our Chairman, Chief Executive 00:00:40.815 -- 00:00:45.621 Officer and President, and Sam Samad, our Chief Financial Officer. 00:00:45.621 -- 00:00:50.968 During this call, we may make forward-looking statements and we'll discuss non-GAAP 00:00:50.968 -- 00:00:56.094 measures. We provide a reconciliation of non-GAAP measures to comparable GAAP 00:00:56.094 -- 00:01:00.067 measures in the tables to our earnings press release. 00:01:00.067 -- 00:01:03.991 Actual results may differ materially from those projected. 00:01:03.991 -- 00:01:09.437 Risks and uncertainties that may affect Quest Diagnostics' future results include, 00:01:09.437 -- 00:01:14.443 but are not limited to, those described in our most recent annual report 00:01:14.443 -- 00:01:20.630 on Form 10-K and subsequently filed quarterly reports on Form 10-2 00:01:20.630 -- 00:01:24.473 and current reports on...